- ホーム
- > 洋書
- > ドイツ書
- > Mathematics, Sciences & Technology
- > Medicine & Pharmacy
- > internal medicine and surgery
Full Description
The proceedings of the International Conference on Dialysis, organized by the Renal Research Institute, New York, are published annually in BLOOD PURIFICATION. Among the topics discussed in the current volume are the potential of erythropoiesis-stimulating agents for tissue protection; treatment of hypertension in dialysis patients; the potential role of gelsolin in dialysis-related protein-energy wasting; salt restriction in dialysis patients; blood-pressure-independent effects of aldosterone on nonepithelial tissues; improvement of the course of cardiovascular disease by modulating immune response; the potential of intestinal therapeutic interventions to reduce uremic toxin generation and absorption; the 'obesity paradox' in dialysis patients; the significance of endothelial progenitor cells and endothelial vesicles in CKD; the management of calcium balance in chronic dialysis patients; and the role of peripheral ultrafiltration in the management of acute decompensated heart failure. Last but not least, several papers are dedicated to regional citrate anticoagulation as an alternative to systemic heparin anticoagulation. Focusing on recent developments in operational areas, technology, biology of uremia and epidemiology, this publication is a helpful reference tool for both clinicians and basic investigators involved in CKD.
Contents
Preface: Kotanko, P.; Levin, N.W.; Ronco, C.; Water for Haemodialysis and Related Therapies: Recent Standards and Emerging Issues: Hoenich, N.A.; Levin, R.; Ronco, C.; The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two Receptors: Brines, M.; Special Considerations for Antihypertensive Agents in Dialysis Patients: Redon, J.; Martinez, F.; Cheung, A.K.; The Potential Role of Plasma Gelsolin in Dialysis-Related Protein-Energy Wasting: Lee, P.S.; Bhan, I.; Thadhani, R.; How to Successfully Achieve Salt Restriction in Dialysis Patients? What Are the Outcomes? Ok, E.; Haemodialysis-Induced Myocardial Stunning in Chronic Kidney Disease - A New Aspect of Cardiovascular Disease: McIntyre, C.W.; Aldosterone in Uremia - Beyond Blood Pressure: Ritz, E.; Koleganova, N.; Immune Mechanisms Involved in Cardiovascular Complications of Chronic Kidney Disease: Stinghen, A.E.M.; Bucharles, S.; Riella, M.C.; Pecoits-Filho, R.; An Approach to Addressing Depression in Patients with Chronic Kidney Disease: Finkelstein, F.O.; Wuerth, D.; Finkelstein, S.H.; Ethnicity and Renal Replacement Therapy: Feehally, J.; The Gut: The Forgotten Organ in Uremia? Schepers, E.; Glorieux, G.; Vanholder, R.; Phosphate Elimination in Modalities of Hemodialysis and Peritoneal Dialysis: Kuhlmann, M.K.; Peritonitis - Does Peritoneal Dialysis Modality Make a Difference? Piraino, B.; Sheth, H.; Reverse Epidemiology, Obesity and Mortality in Chronic Kidney Disease: Modelling Mortality Expectations Using Energetics: Speakman, J.R.; Westerterp, K.R.; Endothelial Progenitor Cells and Endothelial Vesicles - What Is the Significance for Patients with Chronic Kidney Disease? Mohandas, R.; Segal, M.S.; Calcium Balance in Dialysis Is Best Managed by Adjusting Dialysate Calcium Guided by Kinetic Modeling of the Interrelationship between Calcium Intake, Dose of Vitamin D Analogues and the Dialysate Calcium Concentration: Gotch, F.; Levin, N.W.; Kotanko, P.; The Role of Peripheral Ultrafiltration in the Management of Acute Decompensated Heart Failure: Andrade, J.G.; Stadnick, E.; Virani, S.A.; A Selective Cytopheretic Inhibitory Device to Treat the Immunological Dysregulation of Acute and Chronic Renal Failure: Humes, H.D.; Sobota, J.T.; Ding, F.; Song, J.H.; The RAD Investigator Group; Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically Ill: Oudemans-van Straaten, H.M.; A Mathematical Model of Regional Citrate Anticoagulation in Hemodialysis: Thijssen, S.; Kruse, A.; Raimann, J.; Bhalani, V.; Levin, N.W.; Kotanko, P.; Automated Regional Citrate Anticoagulation: Technological Barriers and Possible Solutions: Szamosfalvi, B.; Frinak, S.; Yee, J.; Modeling Hepatitis C Virus Therapies Combining Drugs and Lectin Affinity Plasmapheresis: Tullis, R.H.; Duffin, R.P.; Ichim, T.E.; Joyce, J.A.; Levin, N.W.; Novel Insights into the Pathobiology of the Vascular Access - Do They Translate into Improved Care? Diskin, C.J.
